Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Payables (2016 - 2025)

Historic Payables for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $26.3 million.

  • Bio-Techne's Payables fell 2068.54% to $26.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.3 million, marking a year-over-year decrease of 2068.54%. This contributed to the annual value of $25.3 million for FY2025, which is 3333.6% down from last year.
  • Latest data reveals that Bio-Techne reported Payables of $26.3 million as of Q4 2025, which was down 2068.54% from $30.2 million recorded in Q3 2025.
  • Bio-Techne's 5-year Payables high stood at $38.0 million for Q2 2024, and its period low was $24.1 million during Q4 2022.
  • Over the past 5 years, Bio-Techne's median Payables value was $29.1 million (recorded in 2021), while the average stood at $29.2 million.
  • In the last 5 years, Bio-Techne's Payables skyrocketed by 4785.62% in 2024 and then crashed by 3333.6% in 2025.
  • Bio-Techne's Payables (Quarter) stood at $26.8 million in 2021, then dropped by 9.93% to $24.1 million in 2022, then skyrocketed by 30.76% to $31.5 million in 2023, then increased by 5.1% to $33.1 million in 2024, then fell by 20.69% to $26.3 million in 2025.
  • Its last three reported values are $26.3 million in Q4 2025, $30.2 million for Q3 2025, and $25.3 million during Q2 2025.